Overview

Escitalopram to Placebo in Patients With Localized Pancreatic Cancer

Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
Use of antidepressants for participants with localized pancreatic and periampullary cancer receiving neoadjuvant therapy.
Phase:
Phase 2
Details
Lead Sponsor:
Case Comprehensive Cancer Center
Treatments:
Citalopram